Princeton University Library Catalog

A practical approach to pharmaceutical policy / Andreas Seiter.

Seiter, Andreas [Browse]
Washington, DC : World Bank, c2010.
xxi, 215 p. : ill. ; 23 cm.
Summary note:
"Abundant literature is available on the spectrum of issues relevant to pharmaceutical policy---including regulation, pricing, financing, reimbursement, procurement, and distribution. What has been lacking is a practitioner\u0027s guide for navigating this complex field while considering the various challenges and limitations that characterize political reality. This book meets that need." "There is no "one-size-fits-all" approach to pharmaceutical policy. Even two countries with similar objectives may need to apply different sets of policies, depending on their starting positions, preexisting laws and regulations, perceptions among providers and patients, and implementation capacity. Developed countries may find it hard to reconcile industrial policy and innovation with cost containment in the health sector. Middle-income countries may have to bridge the divide between a demanding urban population and large numbers of poor people in peri-urban and rural areas. Low-income countries may struggle to provide basic essential drugs to their populations through inefficient delivery systems that are still largely state run, while their growing private markets may be flooded with drugs of dubious origin and quality. In each case, policy makers and implementing agencies need to select and combine their policy measures in a way that not only conceptually addresses the main problems but also is practically viable and sustainable." "A Practical Approach to Pharmaceutical Policy discusses the wide range of challenges facing policy makers, presents the current know-how, and provides specific examples of policy packages that can be used in defined circumstances. The book, which focuses on developing countries, equally addresses the issues faced by low-income and middle-income countries. It concludes with a prognosis of how things might evolve in the longer term, assuming convergence toward models that work to reduce the fragmentation of policies and enhance regulatory and economic efficiencies. Such an evolution to a sustainable platform would benefit all stakeholders, but particularly those who, as patients, do not have reliable access to effective and safe medicines." "A Practical Approach to Pharmaceutical Policy will be of interest to pharmaceutical policy makers and advisers in developing countries; people in related fields such as health financing, health service delivery, and health insurance management; representatives of the pharmaceutical industry and associations; academics and students of public health policy, pharmacy, and health economics; and undergraduate and graduate students in related fields."--BOOK JACKET.
Bibliographic references:
Includes bibliographical references and index.
Chapter 1. Pharmaceutical Policy Goals -- Pharmaceutical Policy Framework -- Parameters for Monitoring the Effect and Progress of Pharmaceutical Reforms -- References -- Chapter 2. Introducing the Stakeholders -- Multinational Research-Based Companies -- Multinational Generics Companies -- National Generics Companies -- Brokers -- Procurement Agents -- Importers and Agents -- Wholesalers -- Central Medical Stores -- Retail Pharmacists and Drug Sellers -- Prescribers -- Consumers -- Public Policy Makers: Legislative and Executive -- Regulatory and Executive Agencies -- Expert Commissions and Advisers -- Civil Society Organizations -- International Agencies and Donors -- Public Purchasers -- Payers -- Pharmaceutical Benefit Managers -- Consultants -- Notes -- References -- Chapter 3. Patterns of Dysfunction -- Inadequate Regulation of Core Pharmaceutical Sector Functions -- Lack or Misuse of Funds -- Ineffective or Inefficient Procurement -- Dysfunctional Supply Chains -- Corruption, Abuse of Public Funds, and Unethical Business Practices -- Inadequate Incentives for Providers and Policy Makers -- Medicine Prices Perceived as Too High -- Conflicts between Innovation and Cost Containment -- Conflicts between Industrial Policy and Public Health Objectives -- Irrational or Inappropriate Use of Drugs -- A Tool to Assess the Sector and Diagnose Dysfunctions -- Notes -- References -- Chapter 4. Key Elements of a Successful Pharmaceutical Policy -- Ensuring Access to Safe and Effective Drugs through Well-Designed Supply Chains -- Liberia: Building Up after Conflict -- Notes -- References -- Chapter 8. Pharmaceutical Policy Outlook -- Regulatory Framework -- Drug Prices -- Financing and Management of Drug Benefits -- Effect on Markets and Industry -- General Trend: Convergence toward Models That Work -- References -- Appendix A. A Tool to Assess the Pharmaceutical Sector in a Given Country -- Appendix B. Customized Version of the Assessment Tool (Appendix A) for Use in an Assessment of the Pharmaceutical Sector in Turkey -- Part 1. Quantitative Data -- Part 2. Descriptive Section -- Appendix C. Assessment Tool for Government Procurement Agencies in the Health Sector in India.
Pharmaceutical policy [Browse]
  • 9780821383865 (alk. paper)
  • 0821383868 (alk. paper)
Related name:
C - S